Topics:

Hyperlipidemia

Hyperlipidemia

New research exonerates cholesterol and psychotropic medications as contributing factors in the increased suicide risk among bipolar patients. Lithium seems even to reduce the risk of suicide.

Diuretics and statins appear to increase the risk of new-onset diabetes among those with impaired glucose tolerance and other cardiovascular risk factors.

A study has identified genetic variants that modify lipid responses to lifestyle changes in above-normal-weight people with diabetes.

ApoA-1 is suggested as the best target for reducing cardiovascular risk in patients on statins. Other research suggests that entirely different measures of lipid-related risk may be needed.

Increases in use of antihypertensives and lipid-modifying drugs show good results in a national survey.

Serum levels of fibroblast growth factor 19 and 21 appear to correlate with atherosclerosis. But they differ in their relation to lipid profiles.

A small randomized trial has confirmed previous evidence that adding niacin to a statin in an attempt to raise high-density lipoprotein (HDL) cholesterol levels does not improve cardiovascular outcomes.

Pages

Subscribe to Hyperlipidemia on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.